Glenmark Pharmaceuticals Limited (NSE: GLENMARK)
India
· Delayed Price · Currency is INR
1,760.95
-25.20 (-1.41%)
Oct 10, 2024, 3:30 PM IST
Glenmark Pharmaceuticals Revenue
Glenmark Pharmaceuticals had revenue of 32.44B INR in the quarter ending June 30, 2024, a decrease of -4.63%. This brings the company's revenue in the last twelve months to 128.61B, down -5.53% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.
Revenue (ttm)
128.61B
Revenue Growth
-5.53%
P/S Ratio
3.86
Revenue / Employee
8.58M
Employees
14,989
Market Cap
496.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 126.45B | 9.90B | 8.49% |
Mar 31, 2023 | 116.56B | -6.49B | -5.28% |
Mar 31, 2022 | 123.05B | 13.61B | 12.44% |
Mar 31, 2021 | 109.44B | 2.87B | 2.69% |
Mar 31, 2020 | 106.57B | 7.92B | 8.03% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGlenmark Pharmaceuticals News
- 2 days ago - Pharma stocks update: IPCA Labs up 3.27%, JB Chem 3.18%, Glenmark 2.90%, Torrent Pharma 2.43%, Divis Labs 2.51% - Business Upturn
- 3 days ago - Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83% - Business Upturn
- 17 days ago - Here’s why Glenmark Pharma stock jumps 7.15% in early trade – Check out the reason behind the surge - Business Upturn
- 17 days ago - Glenmark Pharma shares surge over 6% today as Investec initiates ‘FAST Long’, expects 17% upside - Business Upturn
- 17 days ago - Investec initiates ‘FAST Long’ on Glenmark Pharma, expects stock to rally 17% - Business Upturn
- 20 days ago - Glenmark Pharma receives zero observations from U.S. FDA at Aurangabad facility - Business Upturn
- 4 weeks ago - Financial Crime Weekly: Drug Maker To Pay $25M For Price Fixing; Russians Busted For Propaganda; Nigerian Must Pay $5M For Phishing Scheme - Benzinga
- 5 weeks ago - Glenmark Pharma settles US investigation with $25 million payment over five years - Business Upturn